Cellectar Biosciences - 14 Year Stock Price History | CLRB

Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cellectar Biosciences as of January 16, 2019 is 1.96.
Cellectar Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.7900 1.5800 1.9600 1.5800 1.9600 26.45%
2018 7.0838 13.7000 13.7000 1.2900 1.5500 -88.69%
2017 17.2692 12.8000 26.6000 11.2000 13.7000 12.30%
2016 31.0365 73.2000 76.1500 10.5000 12.2000 -83.40%
2015 250.6595 306.0100 355.0000 68.5000 73.5000 -76.21%
2014 552.5469 760.0000 840.0000 198.9500 309.0000 -58.24%
2013 910.9524 1480.0000 1580.0000 600.0000 740.0000 -50.00%
2012 1921.5200 900.0000 4000.0000 860.0000 1480.0000 68.18%
2011 4315.7937 12240.0000 15300.0000 740.0000 880.0000 -90.41%
2010 113632.8571 908820.0000 908820.0000 6120.0000 9180.0000 -98.82%
2009 215997.1429 143820.0000 777240.0000 104040.0000 777240.0000 440.43%
2008 158587.8261 186660.0000 244800.0000 67320.0000 143820.0000 -21.67%
2007 260855.8566 275400.0000 416160.0000 131580.0000 183600.0000 -31.82%
2006 374575.6972 581400.0000 691560.0000 192780.0000 269280.0000 -56.44%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.008B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $123.769B 25.08
Medtronic (MDT) Ireland $115.542B 17.27
Stryker (SYK) United States $60.671B 22.87
Boston Scientific (BSX) United States $50.813B 25.68
Baxter (BAX) United States $35.941B 23.21
Zimmer Biomet Holdings (ZBH) United States $21.248B 13.78
ResMed (RMD) United States $16.483B 31.43
Smith & Nephew SNATS (SNN) United Kingdom $16.432B 0.00
Canopy Growth (CGC) Canada $9.588B 0.00
Bio-Rad Laboratories (BIO) United States $7.128B 45.58
Aurora Cannabis (ACB) Canada $6.987B 36.84
Hill-Rom Holdings (HRC) United States $6.352B 19.88
Perrigo (PRGO) Ireland $6.141B 9.32
Haemonetics (HAE) United States $5.115B 44.98
ICU Medical (ICUI) United States $4.734B 26.38
Insulet (PODD) United States $4.547B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.877B 0.00
Agios Pharmaceuticals (AGIO) United States $3.259B 0.00
Neogen (NEOG) United States $3.061B 47.02
Hutchison China MediTech (HCM) China $2.925B 0.00
NuVasive (NUVA) United States $2.386B 22.20
National Vision Holdings (EYE) United States $2.361B 45.67
Quidel (QDEL) United States $2.098B 27.35
NxStage Medical (NXTM) United States $1.923B 0.00
Aphria (APHA) $1.673B 74.44
Phibro Animal Health (PAHC) United States $1.283B 18.16
AtriCure (ATRC) United States $1.162B 0.00
VAREX IMAGING (VREX) United States $1.000B 20.03
Cardiovascular Systems (CSII) United States $0.952B 1369.50
PetIQ (PETQ) United States $0.782B 20.26
Cerus (CERS) United States $0.771B 0.00
Meridian Bioscience (VIVO) United States $0.716B 22.81
OraSure Technologies (OSUR) United States $0.711B 40.00
Omeros (OMER) United States $0.686B 0.00
Surmodics (SRDX) United States $0.666B 100.86
NanoString Technologies (NSTG) United States $0.659B 0.00
Lantheus Holdings (LNTH) United States $0.634B 19.61
Eagle Pharmaceuticals (EGRX) United States $0.627B 20.10
MacroGenics (MGNX) United States $0.572B 0.00
Quanterix (QTRX) United States $0.477B 0.00
Owens & Minor (OMI) United States $0.468B 5.30
LeMaitre Vascular (LMAT) United States $0.458B 22.51
Evolus (EOLS) United States $0.441B 0.00
TG Therapeutics (TGTX) United States $0.383B 0.00
Utah Medical Products (UTMD) United States $0.316B 20.46
Insys Therapeutics (INSY) United States $0.312B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.302B 0.00
Bovie Medical (APYX) United States $0.288B 0.00
Vapotherm (VAPO) United States $0.275B 0.00
BioLife Solutions (BLFS) United States $0.236B 318.75
Cytosorbents (CTSO) United States $0.232B 0.00
Rockwell Medical (RMTI) United States $0.171B 0.00
Chimerix (CMRX) United States $0.154B 0.00
Surface Oncology (SURF) United States $0.146B 0.00
Fonar (FONR) United States $0.133B 6.66
Chembio Diagnostics (CEMI) United States $0.116B 0.00
United-Guardian (UG) United States $0.095B 19.85
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.032B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Myomo (MYO) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00